Embolization particle, non-bioabsorbable
Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
Public Assessment Report
(PAR)
05-11-2017
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Available from:
Merit Medical Australia Pty Ltd
Class:
Class IIb
Manufactured by:
Biosphere Medical SA Parc des Nations - Paris Nord 2 383 rue de la Belle Etoile, Roissy en France, 95700 France
Therapeutic area:
60938 - Embolization particle, non-bioabsorbable
Therapeutic indications:
HepaSphere Microspheres are indicated for use in embolization of blood vessels with or without delivery of doxorubicin HCI for therapeutic or preoperative purposes in the following procedures; Embolization of hepatocellular carcinoma -Embolization of metastases to the liver. HepaSphere Microspheres loaded with Irinotecan are indicated for use in: Embolization of metastatic colorectal cancer (mCRC)to the liver.
Authorization status:
A
Authorization date:
2016-05-31
